The Medical Defense in Mesothelioma Cases Edward M. Slaughter Hawkins Parnell Thackston & Young LLP 4514 Cole Avenue Dallas, TX 75205.

Slides:



Advertisements
Similar presentations
Challenging Expert Opinions: Every Fiber Does NOT Contribute
Advertisements

These are actual cases to –Stimulate your reading –Test your knowledge of the material Look for the sound icon (often in the upper right hand corner.
STOP DISEASES!!! Pracę przygotowały: Anita Zaręba Kasia Romańczuk Martyna Cal.
Pancreas Cancer Nimisha K. Parekh, MD, MPH
Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis
Pathology Journal Reading
Lung Masses.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Faculty of Medicine - Benha University
DIFFUSE MALIGNANT MESOTHELIOMA GENERAL THORACIC SURGERY CHAPTER 65.
Mesothelioma Livi Eitzman. What is it? Mesothelioma is lung cancer. The cavities within the body encompassing the chest, abdomen, and heart are surround.
Mesothelioma BY: Shane Cloud, Tennyson Hendershott, and Josh Wykoff.
MESOTHELIOMA IS A RARE CANCER THAT OCCURS IN THE THIN LAYER OF TISSUE THAT COVERS THE MAJORITY OF YOUR INTERNAL ORGANS.
Eleni Galani Medical Oncologist
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Neoplasia I Walter C. Bell, M.D..
Dual-time point 18F-FDG PET/CT scan: is it always working?
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
Cancer By Andrew Mallorca and Francis Agbejimi. Causes of Cancer Cancer occurs when cells become abnormal and keep dividing and forming more cells without.
BTS statement on malignant mesothelioma in the UK, 2007 Thorax 2007 Presentation: R3 黃志宇.
Casefinding & Follow-Up Dolores E. McCord, RHIT, CTR Piedmont Hospital Atlanta, Georgia.
LUNG ADENOCARCINOMAS. CLINICOPATHOLOGICAL STUDY WITH RESPECT TO THE UPCOMING NEW CLASSIFICATION AND EGFR-KRAS MUTATION ANALYSIS IMPLICATIONS. First author:
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
NYU Medical Grand Rounds Clinical Vignette Lisa Cioce MD, PGY-2 March 10, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,
Male Reproductive System Kristine Krafts, M.D.. Male Reproductive System Outline Testis Prostate.
ANNUAL SLIDE SEMINAR June Bratislava Slovakia B. Fredrik Petersson MD, PhD Department of Pathology, Karolinska University Hospital Stockholm.
Evaluation of Thyroid Nodules
Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,
Current Asbestos Related Issues Aparna Koppikar, M.D., Ph. D May 21, 2003 National Center for Environmental Assessment.
The Pleura. A mesothelial surface lining the lungs and mediastinum Mesothelial cells designed for fluid absorption Hallmark of disease is the effusion.
April 2014 Dr J King Dr K Syred.  90% mesotheliomas are linked to asbestos exposure  May be eligible for compensation  3 yr survival rate 8%  Subtype.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Mesothelioma BY: Savannah Field & Emily Zahn. OUTLINE Vocabulary Background Information Population Affected Symptoms Diagnosis Treatment Conclusion Works.
Malignant Mesothelioma in Effusions and Fine Needle Aspirates No relationship exists that represents a possible conflict of interest with respect to the.
Pathology of lung cancer: Case #1 presentation. 38-year-old man, non smoker, unremarkable family and personal clinical history productive cough since.
Malignant Peritoneal Mesothelioma with Lung Metastasis.
Cytology of Body Fluid Pleural peritoneal pericardial
DEALING WITH MESOTHELIOMA AND ASBESTOSIS. DEALING WITH MESOTHELIOMA Mesothelioma And Asbestosis are both deadly lung diseases caused due to impermissible.
KCP-771 ( 제출자 ) 원자력병원 R3 허일영. History  71 세 여자환자  6 개월 전부터 운동시 호흡곤란  2 주일 전부터 호흡곤란이 악화  흉부단순촬영에서 오른쪽 폐에 흉수와 무기폐.
MGR REVIEW Malignant Pleural Mesothelioma Depart. Of Pulmonology R3 백승숙.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Diseases of the prostate Osvaldo Rubinstein, MD. Normal urinary bladder with right and left ureters.
Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a complex growth pattern. Imaging plays a crucial role in diagnosis.
case report Title: uterine mass Master: Dr.Mahzooni Resident: Dr.Soleimani 92/7/6.
SURVIVAL RATES Survival rates are another way to express the average cancer patient’s survival time with recent statistics. Because mesothelioma is so.
A Signet Ring Cell Tumor of The Ovary, Diagnosed After Treatment of Hodgkin lymphoma The First Case Of The Literature Dr. Sakir Volkan Erdogan Bakirkoy.
MESOTHELIOMA “The idea of preventive medicine is faintly un-American
W. Scott Campbell, MBA, PhD James R. Campbell, MD
Keith E. Kelly, MD and William H. Culbertson, MD
Radiologic Features of Inflammatory Pseudotumor of the Ureter
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure  Heidi C. Roberts, MD, Demetris A. Patsios,
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.
5A 5B 1A 1B 4A 4B Radiological Differences Between
A Rare Pericardial Malignancy
The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification  Francoise Galateau-Salle, MD, Andrew.
بسم الله الرحمن الرحيم IN THE NAME OF GOD 11/22/2018
Case 1 South Bay Pathology Society May 2009
Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for Small Pulmonary Lesions with Ground-Glass Attenuation  Chia-Hung Lu, MD, FRCR, Cheng-Hsiang.
2018 National Mesothelioma Audit
흉부영상집답회 case review 강동경희대병원 이한나.
Severe Chromosomal Aberrations in Pleural Mesotheliomas with Unusual Mesodermal Features  Michael Krismann, Klaus-Michael Müller, Malgorzata Jaworska,
Case Study 83 Leonidas Arvanitis, MD
Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure  Heidi C. Roberts, MD, Demetris A. Patsios,
A 63-year-old female with lung adenocarcinoma treated with nivolumab, who experienced pseudoprogression. A 63-year-old female with lung adenocarcinoma.
Iris Biopsy in Uveitis: Masquerade Syndrome
Dr. Damjanovich László Dr. Fülöp Balázs
Presentation transcript:

The Medical Defense in Mesothelioma Cases Edward M. Slaughter Hawkins Parnell Thackston & Young LLP 4514 Cole Avenue Dallas, TX 75205

Overview Mesothelioma: The Basics Stains Malignancy Tissue Digestion

MESOTHELIOMA: THE BASICS Pleural –Usually caused by asbestos or some similar fiber, but not always Peritoneal –Maybe caused by asbestos 50% or less Pericardial –Rarely caused by asbestos Testicular mesothelioma –Too uncomfortable to discuss

Pleural Mesothelioma

Caused by prior radiation therapy at the site Other fibers –Erionite (which is not just in Turkey) –Taconite –Maybe any fiber that that is biopersistent? Spontaneous or ideopathic

Peritoneal Mesothelioma Often caused by some other inflammatory process Be on the lookout for: –Prior hernias –Diverticulitis –Hysterectomies –Anything that leads to chronic inflammation

Pericardial and Testicular If you ever see one we can talk about then.

Types of mesothelioma Epithelial Sarcomatoid Biphasic

Epithelial

Sarcomatoid

Biphasic

Extremely Rare Diagnosis Desmoplastic –Really just a rare subtype of sarcomatoid –Hard to diagnose and easily confused with sarcomatoid adenocarcinoma Benign mesothelial hyperplasia –Reactive process that looks like malignant mesothelioma Well differentiated papillary mesothelioma –benign

Desmoplastic

Old men get Mesothelioma Female mesotheliomas are more often from another cause – maybe Really young people usually don’t have sufficient latency If the plaintiff is young look for other causes

Take Away #1 – Be Suspicious Mesothelioma in any location other than the pleura (by the lung) is very suspect Mesothelioma diagnosis with extra words is suspect (wdpm, hyperplasia, etc) Mesothelioma in young people and women is suspect. Be suspicious of the diagnosis in these cases.

STAINS

Stain Limitations Can’t show if process is malignant or benign No single stain can definitively diagnose mesothelioma Glut-1 Caveat

Specificity v. Sensitivity LeuM1 Stain Specific to Adenocarcinoma LeuM1 Stain Does Not Have High Sensitivity though, because does not react with all adenocarcinoma EXAMPLE: LeuM1 STAIN

Other Common Stains Cytokeratins Glycoproteins Calretinin Thrombomodulin HBME-1 Cadherins TTF-1

Stains Used to Diagnose Mesothelioma CK5 - CYTOKERATIN 5/6

Stains Used to Diagnose Mesothelioma MESOTHELIN

Stains Used to Diagnose Mesothelioma THROMBOMODULIN

Stains Used to Diagnose Mesothelioma HBME-1

Stains Used to Diagnose Mesothelioma CALRETININ

Stains Used to Diagnose Mesothelioma WT-1

Take Away #2 – Stains are just a tool IHC stains are NEVER enough for a complete diagnosis They are positive stains and marginally positive stains No one stain is enough Stains cannot distinguish between malignant and benign mesotheliomas

Diagnosing Malignancy Invasion Necrosis Clinical Correlation Other factors

Stromal Invasion “True stromal invasion is by far the most reliable criterion of mesothelial malignancy” Andrew Churg M.D., et al The Separation of Benign and Malignant Mesothelial Proliferations; The American Journal of Surgical Pathology 24(9):1183

…One single slide, 589D4, shows early invasive disease with minimal invasion of fibrous stroma by mesothelial clusters. Minimal Invasion 06/29/05 - Report of Dr. J.F. Legier

6 Days Earlier – Same Pathology 06/23/05 - Report of Dr. J.C. Maddox …based on the clinical history and imaging studies that showed progression of the disease (“malignant mesothelioma on the left with extensive mediastinal invasion…”) … the patient more likely than not had a malignant mesothelioma that caused his death.

And Another Opinion 05/21/07 - Report of I. Allen Feingold Despite all of the above hisotpathological and even immunohistochemical evidence against malignancy in this case, it is important to consider the observation of Dr. Robert Viggiano who saw the patient in consultation and follow up…

Only Seen 10 Times Q: Okay. And out of those 7- or 800 cases, how many times have you had a difficult diagnosis like this, where you had to compare this sort of a benign, reactive process to a malignant mesothelioma? A: Maybe ten times. Q: Okay. And out of those 7- or 800 cases, how many times have you had a difficult diagnosis like this, where you had to compare this sort of a benign, reactive process to a malignant mesothelioma? A: Maybe ten times. Dr. Jacques Legier, pp

Clinical Correlation Just fancy talk for “Did the patient seem like a man with mesothelioma?”

Necrosis Is there dead or dying tissue?

Other Factors Read this: Andrew Churg M.D., et al The Separation of Benign and Malignant Mesothelial Proliferations; The American Journal of Surgical Pathology 24(9):1183

Take away #3 – Not all Mesotheliomas are Malignant Stains don’t prove malignancy Invasion, Necrosis, Clinical Correlation do

Tissue Selection A whole lung is ideal, but not necessary Autopsy, Pneumonectomy or biopsy Uninvolved tissue (not the tumor) The Bigger, The Better Multiple Sites But as little as a gram can be enough

Results of Fiber Burden Analysis Evidence of Fiber Type Amount of Exposure Evidence of Other Exposures Helpful with Alternative Exposure Defenses

Take Away # 4 Digestion can be valuable To prove amphibole exposure To suggest an absence of chrysotile To prove a dose estimate

All 4 Take Aways or The Big Finale Be Suspicious of unusual mesotheliomas (extra words, people under 60, women) Stains are imperfect and don’t prove malignancy - just differentiate between mesothelioma and other processes Malignancy has to be proven – invasion, necrosis, clinical correlation Digestion can prove fiber type and dose, but not diagnosis